News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Drop In FDA Approvals (And New Administration) Rekindles Fears For The Future Of Pharma



1/4/2017 6:53:16 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
2016 was a bummer! After years of rising FDA approvals that swelled to an all-time high of 51 new drugs in 2015, they plummeted to 22 last year—a 57% drop—down to a level not seen since 2010 (Fig 1 and 2). What happened? Reversal to the mean? A harbinger of worse things to come? The answer matters because we spend $328 billion a year to buy our medicines in the U.S. ($697 billion worldwide), and the less productive the industry R&D, the more remote the prospect of enjoying affordable great drugs again.

Read at Forbes


comments powered by Disqus
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES